Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000038261Phase 4Recruiting
Phase 4, randomised, open-label trial of norepinephrine in hypotension (10 arms), sponsored by West China Second University Hospital. Primary endpoints: Blood pressure, ED50 of norepinephrine infusion and 2 more. Started Nov 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000038261.